A Randomized, Placebo Controlled, Double Blind, Parallel Group Multi-Center Study In Order To Investigate Safety And Efficacy Of CP- 690 550 In Subjects With Moderate To Severe Ulcerative Colitis.
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006773/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The hypothesis of the study is that at least one dose of CP 690 550 is superior to placebo
(inactive drug) in inducing remission in patients with moderate to severe ulcerative colitis.
提供机构：
Vivli
创建时间：
2021-04-02
